Clinical Trial Update: A Clinical Trial of TQ-A3334 Tablet After Multiple Administration in Adult Subjects [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating multiple-dose administration of TQ-A3334 tablets in adult subjects with Hepatitis B has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• TQ-A3334 Tablet

Snippet

Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Conditions: Hepatitis B | Phase 1 | Status: COMPLETED